VERACYTE, INC. Cash and Cash Equivalents
VERACYTE, INC. (VCYT) had Cash and Cash Equivalents of $299.52 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-31
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $299.52M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $263.14M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $362.58M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $315.57M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $299.52M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $263.14M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $362.58M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $315.57M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $219.50M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $186.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $239.09M 10-K · filed 2026-02-26 |
| 2024-09-30 | $274.08M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $235.91M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $209.19M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $216.45M 10-K · filed 2026-02-26 |
| 2023-09-30 | $202.46M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $191.14M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $177.89M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $154.25M 10-K · filed 2025-02-28 |
| 2022-09-30 | $170.11M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $153.45M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $163.62M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $173.20M 10-K · filed 2024-02-29 |
| 2021-09-30 | $164.03M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $327.55M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $324.06M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $349.36M 10-K · filed 2023-03-01 |
| 2020-09-30 | $345.08M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $147.45M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $153.13M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $159.32M 10-K · filed 2022-02-28 |
| 2019-09-30 | $195.66M 10-Q · filed 2019-10-22 |
| 2019-06-30 | $192.65M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $67.84M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $78.00M 10-K · filed 2021-02-22 |
| 2018-09-30 | $77.85M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $23.76M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $27.15M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $33.89M 10-K · filed 2020-02-25 |
| 2017-09-30 | $41.20M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $46.46M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $51.51M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $59.22M 10-K · filed 2019-02-25 |
| 2016-09-30 | $31.70M 10-Q · filed 2017-11-07 |
| 2016-06-30 | $38.99M 10-Q · filed 2017-07-31 |
| 2016-03-31 | $47.46M 10-Q · filed 2017-05-03 |
| 2015-12-31 | $39.08M 10-K · filed 2018-02-27 |
| 2015-09-30 | $46.12M 10-Q · filed 2016-11-03 |
| 2015-06-30 | $51.05M 10-Q · filed 2016-08-03 |
| 2015-03-31 | $25.80M 10-Q · filed 2016-05-05 |
| 2014-12-31 | $35.01M 10-K · filed 2018-02-27 |
| 2014-09-30 | $44.00M 10-Q · filed 2015-11-05 |
| 2014-06-30 | $58.00M 10-Q · filed 2015-08-13 |
| 2014-03-31 | $64.24M 10-Q · filed 2015-05-15 |
| 2013-12-31 | $71.22M 10-K · filed 2017-03-01 |
| 2013-09-30 | $15.43M 10-Q · filed 2014-11-13 |
| 2013-06-30 | $20.68M 10-Q · filed 2014-08-14 |
| 2013-03-31 | $7.07M 10-Q · filed 2014-05-09 |
| 2012-12-31 | $14.00M 10-K · filed 2016-03-14 |
| 2012-09-30 | $3.44M 10-Q · filed 2013-11-25 |
| 2011-12-31 | $7.57M 10-K · filed 2015-03-25 |
| 2010-12-31 | $2.77M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |